PT  - JOURNAL ARTICLE
AU  - Wang, Baohui
AU  - Wang, Hailin
AU  - Li, Tingting
AU  - Sun, Jianming
AU  - Huang, Xiao
AU  - Lin, Huan
AU  - Dan, Yujia
AU  - Qin, Yurong
AU  - Zhang, Peng
AU  - Guan, Jing
AU  - Wu, Guojin
AU  - Hou, Xiaofan
AU  - Lai, Shoupeng
AU  - Kang, Xiaoqiang
AU  - Ling, Hong
TI  - 841 LBL-019, a novel TNFR2 agonist antibody, shows potent anti-tumor efficacy through preferentially activating CD8+ T cells and alleviating the suppressive effect of Treg cells
AID  - 10.1136/jitc-2023-SITC2023.0841
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A939--A939
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A939.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A939.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.